Tag Archives: Breast Cancer

Cancer Research, Immuno-Oncology, Immunotherapy, Living with Cancer

Personalized Vaccines Are Recognized as the Future for Cancer Treatment

January 28, 2015 heavy

Vaccines save lives by utilizing the patient’s immune system to attack harmful cells. Much like flu vaccines prepare the person’s body to defend against pathogens, cancer prevention vaccines are given to people who do not have cancer to help their body identify and destroy infections known to lead to cancer. Treatment vaccines are for people who are already diagnosed with cancer. Issels® Integrative Immuno-Oncology uses non-toxic vaccine and cell therapy that is prepared from the patient’s own blood.

Washington University study

A recent study by scientists at Washington University found personalized cancer treatment was able to cure 90 percent of the mice used in the study that had advanced muscle cancer. This success prompted Alumni Professor of Pathology and Immunology for the university Robert Schreiber, PhD, who was senior author of the study, to say personalized cancer vaccines should be used to treat cancer in humans right away.

Immune-based treatments

Years of research on cancer genetics and how the immune system interacts with cancer have made new vaccines and treatments possible. Scientists agree immunotherapy is the best path to a cancer cure.

A personalized vaccine requires samples from the DNA of the individual’s tumor and healthy tissue. This aspect of creating an effective vaccine is difficult because cancer cells develop from the healthy cells of the person and are not easily recognized as harmful by the immune system. Despite the difficulties, experts agree that this type of integrative strategy is the best path to successfully treating cancer.

To find out more about the cutting edge non-toxic treatments and cell therapies utilized by Issels® Integrative Immuno-Oncology, contact us by phone or via our short online form.

Cancer Care Tips, Living with Cancer, Uncategorized

Ten Herbs and Vitamins to Steer Clear of While in Chemo or Radiation

January 26, 2015 heavy

Herbs and other supplements can provide an added boost for patients with cancer. In many cases, alternative cancer therapies can succeed where standard therapies have failed.

However, in some cases, complementary medicines that are recommended for some patients can actually have adverse effects on certain other patients. An herb may be excellent for one form of cancer and hazardous for another. In all cases, patients should confirm recommendations with a doctor before taking supplements.

These products may not be prescription drugs, but they do have a powerful ability to interact with chemotherapy, radiation treatments, and anti-cancer medicines.

Below are common supplements with anti-cancer properties that may also cause serious problems if taken during other treatments. Consult the American Cancer Society website or other trusted sources for a helpful guide to vitamins, minerals, and herbal medicines.

1. Fish oil: May induce bleeding if you have a low platelet count.

2. Ginger: Also may induce bleeding.

3. Turmeric: Could decrease the effectiveness of chemotherapy — or increase the effects, with toxic results.

4. Coenzyme Q10: Antioxidant properties may interfere with chemotherapy and radiation.

5. Milk thistle: May affect estrogen levels, which could pose an issue for breast or ovarian cancer.

6. Licorice: Also may affect estrogen levels.

7. Green tea: Negates the benefits of certain anti-cancer drugs.

8. Reishi mushroom: May interfere with certain drugs or chemotherapy.

9. Astragalus: May interfere with certain immunosuppressants.

10. Acidophilus: May cause infections or other problems if taken during chemotherapy.

Despite the risks for some patients, these substances do have successful results for many people. Issels® Integrative Immuno-Oncology can always help with information about alternative cancer treatment.

Alternative Cancer Treatment, Cancer Research, News

Google’s Nano-Pill to Detect Cancer

January 23, 2015 heavy

It might seem like it’s too good to be true, but what Google is doing is far from science fiction. They’re working on developing a nano-pill that can detect cancer, as well as other diseases and illnesses. The nano-pill is still being worked on, but the folks at Google are confident that they have the knowledge and capability they need to make their newest idea a reality.

How does it work?

The nano-pill works by releasing nano particles into the body that are drawn to cancer cells like a magnet. The particles latch on and any information that’s gathered about the cancer cells is sent to a sensor. The best part is that people can begin to get treatments before they would normally have them under traditional detection methods.

According to a recent article on Wired.com, it’s relatively easy for academic researchers to pinpoint what might work best for such a project, but it takes a team of qualified engineers, scientists and technicians to design the hardware for such a product. That’s where Google comes in, and they’ve brought their best team members to the table.

Of course, the challenge is going to be in the clinical trials. Some trials have begun on artificial human limbs, but there is still much research to be done before the nano pill is ready to take the next step. It might be a few years before it hits the market.

Non-traditional cancer treatments are what we specialize in, here at Issels®. If you’ve been looking for alternative cancer treatments for yourself or a loved one, please contact us. We would love to talk with you about our options.

Living with Cancer

Cancer Cells Show Sensitivity to Metabolic Stress

January 21, 2015 heavy

Every day it seems researchers are learning something new about cancer. Recently, it was discovered that cancer cells could be vulnerable to metabolic stress. According to an article on Medical News Today’s website, this discovery could pave the way for new cancer therapies that won’t be harmful to normal cells.

How Tumor Cells Get Stressed

Research has shown that a tumor is usually not made up of identical cells. When someone goes through chemotherapy the cells frequently change. This chromosomal instability causes cancer cells to stress out. When they are stressed, it could lead to metabolic disruption.

What is metabolic stress? Metabolism is essential to life. It’s what turns food into energy. Metabolic stress puts a strain on the immune system, and could diminish muscle strength.

Experiments are currently being conducted on Drosophila flies that will show how much stress unstable cells can tolerate. Dr. Gregory is hoping this study will be the jumping-off point to developing treatments that have no side effects.

Ways to Avoid Metabolic Stress

According to the article, chemotherapy is toxic to all dividing cells. That’s why there are so many chemotherapy side effects such as hair loss, pain, and infections. The immunotherapy treatments we provide at Issels® Integrative Immuno-Oncology have been shown to stop the growth of unstable tumor cells in many patients.

Other ways to avoid metabolic stress is by radically changing one’s eating habits and by working out. Exercise has also been linked to cancer prevention and reduced cancer recurrence.

If you’re looking for a way to treat cancer that doesn’t involve weakening your body or the use of toxic chemicals, contact us at Issels® Integrative Immuno-Oncology. Our experienced doctors are happy to walk you through our immunotherapy treatments.

Alternative Cancer Treatment, Cancer Research

The Tumor Micro Environment Plays a Role in the Spread of Liver Cancer

January 19, 2015 heavy

Despite recent advancements in cancer treatments, hepatocellular carcinoma (HCC) is one of only a few forms that has seen a steady increase in occurrences over the past few years. Scientists have identified a significant difference in this form that could hold the key to reversing that trend.

What is HCC?

HCC is the most common form of liver cancer. Close to 750,000 new cases are reported worldwide each year and it ranks as the third leading cause of cancer-related deaths. In addition, large numbers of patients develop metastases or suffer from reoccurrence of the tumors.

HCC’s Link to Liver Diseases

While most cancers arise within relatively healthy tissues, HCC most frequently develops in livers that are chronically diseased due to hepatitis, inflammation or cirrhosis. This hepatitis-B virus (HBV)-associated HCC creates a microenvironment that contributes toward tumor growth.

Three scientists from the United States and China teamed up for a report on the topic that was published in the Beijing-based National Science Review. The article is a summary of the complex interaction in the HBV-associated HCC microenvironment and how it impacts the onset, progression and metastasis of the cancer.

What Does the Future Hold?

HBV in effect acts as a traffic cop for the intricate network of cells that make up the microenvironment. Scientists are encouraged that this function can be harnessed to help create a more effective treatment for HCC.

Many of the patients receiving our alternative cancer treatment have experienced remission of liver cancer as well as several other forms. Please contact us for more information about the Issels® difference.

Living with Cancer

Bladder Cancer Breakthrough Highlights

January 16, 2015 heavy

After decades without major developments, the study of advanced bladder cancer has reached a new breakthrough thanks to an alternative cancer treatment.

An immunotherapy medicine has been found by researchers to shrink or eliminate tumors. Patients who have not responded positively to chemotherapy and other standard therapies have improved or entered remission, based on the initial findings.

The immunotherapy has been awarded “Breakthrough Therapy Designation” by the U.S. Food and Drug Administration. This means the FDA will expedite the review process to help patients with the serious disease receive the treatment as quickly as possible.

Promising Evidence for Bladder Cancer Immunotherapy

In a British trial, advanced bladder cancer patients received a new medication developed by the Swiss lab Roche.

Patients carrying the PD-L1 protein responded best to the treatment. The results:

Tumors shrank in 43 percent of patients within 6 weeks of immunotherapy

After 12 weeks, 52 percent had shrunken tumors

2 out of 30 patients had no signs of cancer following the treatment

Among PD-L1 negative patients, 11 percent saw a reduction in tumor size.

While this particular cancer immunotherapy awaits full FDA approval, the signs are encouraging. Only common side effects of cancer treatments were reported, including loss of appetite and tiredness.

Bladder cancer has long been considered one of the most difficult forms of cancer. This breakthrough provides an alternative to chemotherapy, which has for years been the only treatment option for advanced cases.

Issels® champions alternative cancer treatments, including many immunotherapies that are considered breakthroughs. Get in touch with us to discuss the latest cancer treatment options we provide.

The Issels News Blog